Deoxyglucose kinetics in a rat brain tumor

Area of Science:

• Neuroscience
• Biochemistry
• Medical Imaging

Background:

• Accurate quantitation of local glucose metabolic rates (LMRglc) in abnormal tissues like brain tumors is crucial.
• The 2-deoxyglucose (DG) method requires knowledge of tissue rate constants and the lumped constant for precise measurements.

Purpose of the Study:

• To measure deoxyglucose rate constants in an experimental intracerebral glioma in rats.
• To calculate LMRglc for both normal cerebrum and glioma tissue.
• To assess the reliability of tissue activity alone for determining relative metabolic rates in abnormal tissues.

Main Methods:

• Utilized a dual tracer [(3H)-DG and (14C)-DG] method in 24 awake rats with intracerebral gliomas.
• Collected tissue samples at multiple time points (2-180 min) post-injection for liquid scintillation counting.
• Employed parameter estimation to determine rate constants (K1, k2, k3, k4) and calculated LMRglc assuming a lumped constant of 0.5.

Main Results:

• Normal cerebrum rate constants: K1=0.258 ml/g/min, k2=0.406 min⁻¹, k3=0.075 min⁻¹, k4=0.0103 min⁻¹; LMRglc=65.1 μmol/100 g/min.
• Glioma rate constants: K1=0.108 ml/g/min, k2=0.126 min⁻¹, k3=0.040 min⁻¹, k4=0.0019 min⁻¹; LMRglc=41.7 μmol/100 g/min.
• Significantly lower k4 in glioma led to persistently higher tissue activity at later time points.

Conclusions:

• Tissue activity measurements alone are inadequate for assessing relative glucose metabolic rates in abnormal tissues like gliomas, especially at late time points.
• The determined rate constants provide essential parameters for accurate LMRglc quantification using the DG method in glioma models.
• Understanding kinetic differences is vital for interpreting DG-based metabolic imaging in brain tumors.